Studies have shown that among 27 patients with colorectal cancer, 19 patients with low PCIF1 expression have a significantly longer survival time than 8 patients with high PCIF1 expression, indicating that the dose of PCIF1 is also related prognosis [29]. The gene discussed is PCIF1; the disease is colorectal cancer.